Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Strides Pharma Science Yönetim
Yönetim kriter kontrolleri 3/4
Strides Pharma Science's CEO'su Badree Komandur, Jun2024 tarihinde atandı, in görev süresi bir yıldan az. in toplam yıllık tazminatı ₹ 44.00M olup, şirket hissesi ve opsiyonları dahil olmak üzere 83% maaş ve 17% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.027% ine doğrudan sahiptir ve bu hisseler ₹ 35.03M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 0.3 yıl ve 6.1 yıldır.
Anahtar bilgiler
Badree Komandur
İcra Kurulu Başkanı
₹44.0m
Toplam tazminat
| CEO maaş yüzdesi | 83.0% |
| CEO görev süresi | less than a year |
| CEO sahipliği | 0.03% |
| Yönetim ortalama görev süresi | less than a year |
| Yönetim Kurulu ortalama görev süresi | 6.1yrs |
Son yönetim güncellemeleri
Recent updates
After Leaping 29% Strides Pharma Science Limited (NSE:STAR) Shares Are Not Flying Under The Radar
Aug 14
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)
Apr 04Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Feb 29Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story
Dec 23We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt
Sep 26Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Jun 08Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
Aug 02Is Strides Pharma Science (NSE:STAR) A Risky Investment?
Jun 25Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Dec 21Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50
Jul 28Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)
Apr 13Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?
Mar 04These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively
Feb 15Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?
Jan 26The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It
Jan 11
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?
Dec 28Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -₹475m |
| Mar 31 2024 | ₹44m | ₹37m | -₹1b |
| Dec 31 2023 | n/a | n/a | -₹2b |
| Sep 30 2023 | n/a | n/a | -₹2b |
| Jun 30 2023 | n/a | n/a | -₹924m |
| Mar 31 2023 | ₹44m | ₹36m | -₹2b |
| Dec 31 2022 | n/a | n/a | -₹2b |
| Sep 30 2022 | n/a | n/a | -₹2b |
| Jun 30 2022 | n/a | n/a | -₹4b |
| Mar 31 2022 | ₹46m | ₹38m | -₹5b |
| Dec 31 2021 | n/a | n/a | -₹4b |
| Sep 30 2021 | n/a | n/a | -₹3b |
| Jun 30 2021 | n/a | n/a | -₹543m |
| Mar 31 2021 | ₹44m | ₹33m | ₹3b |
| Dec 31 2020 | n/a | n/a | ₹28m |
| Sep 30 2020 | n/a | n/a | ₹589m |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹37m | ₹23m | ₹492m |
| Dec 31 2019 | n/a | n/a | ₹3b |
| Sep 30 2019 | n/a | n/a | ₹2b |
| Jun 30 2019 | n/a | n/a | ₹745m |
| Mar 31 2019 | ₹32m | ₹18m | ₹840m |
| Dec 31 2018 | n/a | n/a | -₹93m |
| Sep 30 2018 | n/a | n/a | ₹139m |
| Jun 30 2018 | n/a | n/a | ₹415m |
| Mar 31 2018 | ₹26m | ₹17m | ₹544m |
Tazminat ve Piyasa: Badree 'ın toplam tazminatı ($USD 523.95K ) Indian pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 473.78K ).
Tazminat ve Kazançlar: Badree 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Badree Komandur (52 yo)
less than a year
Görev süresi
₹44,000,000
Tazminat
Mr. Badree Komandur had been the Chief Financial Officer and Executive Director of Finance of Strides Pharma Science Limited (formerly known as Strides Shasun Limited) since August 1, 2013 until June 1, 20...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder & Executive Chairperson | 34.3yrs | ₹120.00m | 2.11% ₹ 2.8b | |
| MD & Group CEO | less than a year | ₹44.00m | 0.027% ₹ 36.5m | |
| Compliance Officer & Company Secretary | 7.7yrs | ₹6.85m | Veri yok | |
| Executive Director of Business Development & Director | less than a year | ₹7.50m | 0.064% ₹ 85.2m | |
| Group CFO & Chief Investor Relations Officer | less than a year | Veri yok | Veri yok | |
| Chief Operating Officer | less than a year | Veri yok | Veri yok | |
| Group General Counsel | no data | Veri yok | Veri yok | |
| Group Chief Human Resource Officer | no data | Veri yok | Veri yok | |
| Executive Vice President of Operations | no data | Veri yok | Veri yok | |
| Senior Vice President of Strides Pharma Inc. | no data | Veri yok | Veri yok | |
| Chief Quality Officer | no data | Veri yok | Veri yok | |
| Chief Information Technology Officer | no data | Veri yok | Veri yok |
0.3yrs
Ortalama Görev Süresi
48yo
Ortalama Yaş
Deneyimli Yönetim: STAR 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder & Executive Chairperson | 34.3yrs | ₹120.00m | 2.11% ₹ 2.8b | |
| MD & Group CEO | 7.4yrs | ₹44.00m | 0.027% ₹ 36.5m | |
| Executive Director of Business Development & Director | less than a year | ₹7.50m | 0.064% ₹ 85.2m | |
| Independent Director | 7.4yrs | ₹4.00m | Veri yok | |
| Executive Chairman of Arrow Pharmaceuticals Pty Ltd | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Independent Director | 4.8yrs | ₹4.00m | 0.0024% ₹ 3.2m | |
| Independent Director | less than a year | ₹800.00k | Veri yok |
6.1yrs
Ortalama Görev Süresi
62.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: STAR 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.1 yıldır).